Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Jun 8, 2023. (Total: 217765Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 5 (of 5 Records)

Query Trace: Breast Neoplasms and SLCO1A2[original query]
Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk.
Breast cancer research and treatment 2011 Jan 125 (2): 563-9.
Justenhoven Christina, Schaeffeler Elke, Winter Stefan, Baisch Christian, Hamann Ute, Harth Volker, Rabstein Sylvia, Spickenheuer Anne, Pesch Beate, Brüning Thomas, Ko Yon-Dschun, Schwab Matthias, Brauch Hiltr
High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial.
Breast cancer research and treatment 2015 Sep 153 (2): 383-9.
Callens Céline, Debled Marc, Delord Marc, Turbiez-Stalain Isabelle, Veyret Corinne, Bièche Ivan, Brain Etien
First genome-wide association study on rocuronium dose requirements shows association with SLCO1A2. GWAS Catalog
British journal of anaesthesia 2021 3 126 (5): 949-957.
Ahlström Sirkku, Bergman Paula, Jokela Ritva, Ottensmann Linda, Ahola-Olli Ari, Pirinen Matti, Olkkola Klaus T, Kaunisto Mari A, Kalso Ei
SLC46A1 Haplotype with Predicted Functional Impact has Prognostic Value in Breast Carcinoma.
Molecular diagnosis & therapy 2021 1 25 (1): 99-110.
Hlavac Viktor, Vaclavikova Radka, Brynychova Veronika, Dvorak Pavel, Elsnerova Katerina, Kozevnikovova Renata, Raus Karel, Kopeckova Katerina, Mestakova Sona, Vrana David, Gatek Jiri, Soucek Pav
Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects.
Pharmacogenetics and genomics 2022 11 33 (1): 10-18.
Keller Denise N, Medwid Samantha J, Ross Cameron D, Wigle Theodore J, Kim Richard
TOP